Nexavar

Latest stories

1d
The Columbian
Bayer-Monsanto potential pairing of giantsa permanent contraceptive that blocks the fallopian tubes; hemophilia treatment
Bayer-Monsanto potential pairing of giants
The Columbian / Posted yesterday
a permanent contraceptive that blocks the fallopian tubes; hemophilia treatments Kogenate and Kovaltry; cancer drugs Nexavar, Stivarga and Xofigo; antibiotics Avelox and Cipro, erectile dysfunction pill Levitra, Betaseron for multiple... Read more
3 related stories
1d
Deseret News
Bayer and Monsanto could combine plant, pet, people productsa permanent contraceptive that blocks the fallopian tubes; hemophilia treatment
Bayer and Monsanto could combine plant, pet, people products
Deseret News / Posted yesterday
a permanent contraceptive that blocks the fallopian tubes; hemophilia treatments Kogenate and Kovaltry; cancer drugs Nexavar, Stivarga and Xofigo; antibiotics Avelox and Cipro, erectile dysfunction pill Levitra, Betaseron for multiple... Read more
3 related stories
2d
Crain's Chicago Business
Bayer and Monsanto could combine plant, pet, people productsa permanent contraceptive that blocks the fallopian tubes; hemophilia treatment
Bayer and Monsanto could combine plant, pet, people products
Crain's Chicago Business / Posted 2 days ago
a permanent contraceptive that blocks the fallopian tubes; hemophilia treatments Kogenate and Kovaltry; cancer drugs Nexavar, Stivarga and Xofigo; antibiotics Avelox and Cipro, erectile dysfunction pill Levitra, Betaseron for multiple... Read more
3 related stories
2d
Daily Herald
Bayer and Monsanto could combine plant, pet, people productsa permanent contraceptive that blocks the fallopian tubes; hemophilia treatment
Bayer and Monsanto could combine plant, pet, people products
Daily Herald / Posted 2 days ago
a permanent contraceptive that blocks the fallopian tubes; hemophilia treatments Kogenate and Kovaltry; cancer drugs Nexavar, Stivarga and Xofigo; antibiotics Avelox and Cipro, erectile dysfunction pill Levitra, Betaseron for multiple... Read more
3 related stories
9d
The Economic Times
IPR policy lacks specifics, won't be enough to foster innovation: Lobby groupsput India on a watch list for rejecting a patent for the Novartis' Glivec and f
IPR policy lacks specifics, won't be enough to foster innovation: Lobby groups
The Economic Times / Posted 9 days ago
put India on a watch list for rejecting a patent for the Novartis' Glivec and for granting a compulsory licence for Bayer's Nexavar, both cancer drugs. "We need to see the Modi administration's expressed commitment to IP matched by decisive legal... Read more
15d
News-Medical-Net
MUSC Hollings Cancer Center receives $8.9 million grant to explore signaling in sphingolipidswill enroll patients who have experienced tumor progression following treatment
MUSC Hollings Cancer Center receives $8.9 million grant to explore signaling in sphingolipids
News-Medical-Net / Posted 15 days ago
will enroll patients who have experienced tumor progression following treatment with first-line single-agent sorafenib (Nexavar®). The SK2 selective inhibitor was developed by Charles Smith, Ph.D., while at MUSC and later sold to RedHill... Read more
20d
News-Medical-Net
Bayer-new phase 3 liver cancer dataincluding the Boxed Warning, visit http://labeling.bayerhealthcare.com/html/pro
Bayer-new phase 3 liver cancer data
News-Medical-Net / Posted 20 days ago
including the Boxed Warning, visit http://labeling.bayerhealthcare.com/html/products/pi/Stivarga_PI.pdf. About NEXAVAR® (sorafenib) Tablets NEXAVAR is approved in the U.S. for the treatment of patients with unresectable hepatocellular... Read more
23d
asianage
FDI during April-February jumps to $37.53 billion: Nirmala Sitharamanto manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to
FDI during April-February jumps to $37.53 billion: Nirmala Sitharaman
asianage / Posted 23 days ago
to manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by patent-holder Bayer Corp., under CL. As per the World Trade... Read more
4 related stories
23d
asianage
FDI during April-February jumps to $37.53 billion Nirmala Sitharamanto manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to
FDI during April-February jumps to $37.53 billion Nirmala Sitharaman
asianage / Posted 23 days ago
to manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by patent-holder Bayer Corp., under CL. As per the World Trade... Read more
4 related stories
23d
dna
FDI during Apr-Feb jumps to Rs 2.5 lakh crore: Nirmala Sitharamanto manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to
FDI during Apr-Feb jumps to Rs 2.5 lakh crore: Nirmala Sitharaman
dna / Posted 23 days ago
to manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by patent-holder Bayer Corp., under CL. As per the World Trade... Read more
4 related stories
23d
The Economic Times
FDI during April-February jumps to $37.53 billion: Nirmala Sitharamanto manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to
FDI during April-February jumps to $37.53 billion: Nirmala Sitharaman
The Economic Times / Posted 23 days ago
to manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by patent-holder Bayer Corp., under CL. As per the World Trade... Read more
4 related stories
23d
The Financial Express
FDI during April-February jumps to $37.53 bn: Nirmala Sitharamanto manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to
FDI during April-February jumps to $37.53 bn: Nirmala Sitharaman
The Financial Express / Posted 23 days ago
to manufacture it. In March 2012, Hyderabad-based Natco Pharma was allowed to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by patent-holder Bayer Corp., under CL. As per the World Trade... Read more
4 related stories

People in this news